alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1

                           CERTIFICATIONS PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Annual Report of VendingData Corporation (the
"Company") on Form 10-KSB for the year ended December 31, 2004, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), we,
Mark R. Newburg, Chief Executive Officer, and Arnaldo F. Galassi, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      1.    The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      2.    The information contained in the Report fairly presents, in all
            material respects, the financial condition and result of operations
            of the Company.


By:                                                      Dated: December 7, 2005
       -------------------------------------
       Mark R. Newburg
Title: Chief Executive Officer, Principal
       Executive Officer


By:                                                      Dated: December 7, 2005
       -------------------------------------
       Arnaldo F. Galassi
Title: Chief Financial Officer of VendingData
       Corporation

      This certification is made solely for the purposes of 18 U.S.C. Section
1350, subject to the knowledge standard contained therein, and not for any other
purpose.
[Federal Register Volume 65, Number 128 (Monday, July 3, 2000)]
[Notices]
[Page 41079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-16722]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Optimizing Strategies to Provide Sexually Transmitted 
Disease (STD) Partner Services, PA# 00080.

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: Optimizing Strategies to Provide Sexually 
Transmitted Disease (STD) Partner Services, PA# 00080.
    Times and Dates: 8:30 a.m-9 a.m., August 29, 2000 (Open), 9 
a.m.-4:30 p.m., August 29, 2000 (Closed), 8:30 a.m.-4:30 p.m., 
August 30, 2000 (Closed).
    Place: Centers for Disease Control and Prevention, 12 Corporate 
Square Boulevard, Building 12, Conference Rooms 1203 and 1307, 
Atlanta, GA 30329.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 00080.
    Contact Person for more Information: Beth Wolfe, Prevention 
Support Office, National Center for HIV, STD, and TB Prevention, 
CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail 
<a href="/cdn-cgi/l/email-protection#3d58524a0c7d5e595e135a524b"><span class="__cf_email__" data-cfemail="4a2f253d7b0a292e29642d253c">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


    Dated: June 23, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 00-16722 Filed 6-30-00; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
200P16

#### North Carolina State Bar v. Dianne Michele Carter El Bey v. State of North Carolina, Paul G. Gessner, Individually and as Judge, North Carolina State Bar, David R. Johnson, Individually and as Judge, and Jennifer Knox, Individually and as Clerk

Def’s *Pro Se*Motion for Writ of Prohibition for Usurpation of Power

Dismissed 06/07/2016

Ervin, J.,

recused
**EXHIBIT 21.1**

 

SUBSIDIARIES OF THE REGISTRANT 

 

Bank of Florida N.A. f/k/a Citizens National Bank of Southwest Florida, Naples, Collier County, Florida. 

Organized under the laws of the United States. 

 

Bank of Florida Trust Company f/k/a Citizens Capital Management, Inc., Naples, Collier County, Florida. 

Organized under the laws of the State of Florida. 

 

Bank of Florida, Ft. Lauderdale, Broward County, Florida. 

Organized under the laws of the State of Florida. 

 

35
No. 11A961.

#### Abdurakhmanov *v.*Holder, Attorney General.

C. A. 6th Cir. Application for stay,

addressed to The Chief Justice and referred to the Court, denied.
No. 11-1152.

#### Starkey *v.*Minor Miracle Productions, LLC, et al.

Sup. Ct. Idaho. Certiorari denied.
NOTE: This disposition is nonprecedential.

 

United States Court of Appeals 

for the Federal Circuit ______________________ 

SHOCKWAVE MEDICAL, INC.,

Appellant

v.

CARDIOVASCULAR SYSTEMS, INC.,

Appellee

______________________ 

2020-2251

______________________ 

Appeal from the United States Patent and Trademark 

Office, Patent Trial and Appeal Board in No. IPR2019-

00409.

______________________ 

JUDGMENT

______________________ 

DAVID C. MCPHIE, Irell & Manella LLP, Newport 

Beach, CA, argued for appellant. Also represented by 

STEPHEN PAYNE; MICHAEL RICHARD FLEMING, Los Angeles, 

CA; WILLIAM ALCIATI, GREG GARDELLA, Gardella Grace PA, 

Washington, DC. 

 MARK CHRISTOPHER NELSON, Barnes & Thornburg 

LLP, Dallas, TX, argued for appellee. Also represented by 

JUANITA DELOACH; JEFFREY STONE, Minneapolis, MN. 

 ______________________ 

Case: 20-2251 Document: 63 Page: 1 Filed: 01/18/2022
THIS CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

 PER CURIAM (PROST, CHEN, and HUGHES, Circuit 

Judges).

AFFIRMED. See Fed. Cir. R. 36.

 

 ENTERED BY ORDER OF THE COURT 

 

January 18, 2022

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court

Case: 20-2251 Document: 63 Page: 2 Filed: 01/18/2022
No. 11-9682.

#### Ramsey *v.*United States.

C. A. 11th Cir. Certiorari denied.
EXHIBIT 31.1

                     Rule 13a-14(a)/15d-14(a) Certification
                     --------------------------------------

I, Frank P. Reilly, certify that:

1. I have reviewed this Quarterly Report on Form 10-QSB for the quarter ended
March 31, 2008 of NuState Energy Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15-15(e)) for the
small business issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

(b) Evaluated the effectives of the small business issuer's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that occurred during the small business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of the issuer's board of directors (or persons performing the
equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

                                   /s/ Frank P. Reilly
                                   -------------------------
                                   Frank P. Reilly
                                   Chief Executive Officer
May 20, 2008
No. 11-9668.

#### Devine *v.*United States.

C. A. 4th Cir. Cer-tiorari denied.
In accordance with Departmental policy, 28 CFR 50.7, notice is hereby given that a proposed consent decree in Civil Action No. 99-2673-Civ-T-24B was lodged with the United States District Court for the Middle District of Florida on November 23, 1999.

In this action the United States sought injunctive relief and recovery of response costs under Sections 106(a) and 107 of CERCLA, 42 U.S.C. 9606(a) and 9607, with respect to the Stauffer Chemical Superfund Site in Tarpon Springs, Florida (“the Site”).

Under a proposed Consent Decree, Atkemix Thirty-Seven, Inc., the present owner and operator of the Site, and Rhone-Poulenc Ag Company, Inc., the former owner and operator of the Site, have agreed to perform the remedy chosen by EPA to clean up the Site, pay the government's remaining past response costs, and pay future response costs, in settlement of the government's claims under Sections 106 and 107 of CERCLA, 42 U.S.C. 9606 and 9607.

                    The Department of Justice will extend the public comment period for an additional thirty (30) days and will receive comments until February 22, 2000 relating to the proposed consent decree. Comments should be addressed to the Assistant Attorney General for the Environment and Natural Resources Division, Department of Justice, Washington, DC 20530, and should refer to                     *United States*                     v.                     *Atkemix Thirty-Seven, Inc., and Rhone-Poulenc Ag. Company, Inc.,*                     (M.D.F1.), DOJ #90-11-2-1227/1.                

The proposed consent decree may be examined at the Office of the United States Attorney, 400 North Tampa Street, Suite 3200, Tampa Florida 33602; the Region 4 Office of the Environmental Protection Agency, 61 Forsyth Street, Atlanta, Georgia 30303, and at the Consent Decree Library, Post Office Box 7611, Washington, DC 20044-7611, (202) 514-1547. A copy of the proposed consent decree may be obtained by mail from the Consent Decree Library, Post Office Box 7611, Washington, DC 20044-7611. In requesting a copy please refer to the referenced case and enclose a check in the amount of 25 cents per page for reproduction costs, payable to the Consent Decree Library.

Joel M. Gross, 

Chief, Environmental Enforcement Section, Environment and Natural Resources Division.

[FR Doc. 00-1676 Filed 1-24-00; 8:45 am]

BILLING CODE 4410-15-M
{"version":"1.0","provider_name":"U.S. Court of Appeals for the Federal Circuit","provider_url":"https:\/\/cafc.uscourts.gov","author_name":"25005pwpadmin","author_url":"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/","title":"21-2275: PERSONALIZED MEDIA COMMUNICATIONS, LLC v. APPLE INC. [OPINION], Precedential - U.S. Court of Appeals for the Federal Circuit","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HbuHyWocSJ\"><a href=\"https:\/\/cafc.uscourts.gov\/01-20-2023-21-2275-personalized-media-communications-llc-v-apple-inc-opinion-21-2275-opinion-1-20-2023_2066571\/\">21-2275: PERSONALIZED MEDIA COMMUNICATIONS, LLC v. APPLE INC. [OPINION], Precedential<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cafc.uscourts.gov\/01-20-2023-21-2275-personalized-media-communications-llc-v-apple-inc-opinion-21-2275-opinion-1-20-2023_2066571\/embed\/#?secret=HbuHyWocSJ\" width=\"600\" height=\"338\" title=\"“21-2275: PERSONALIZED MEDIA COMMUNICATIONS, LLC v. APPLE INC. [OPINION], Precedential” — U.S. Court of Appeals for the Federal Circuit\" data-secret=\"HbuHyWocSJ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"OPINION Posted: PERSONALIZED MEDIA COMMUNICATIONS, LLC v. APPLE INC. [OPINION](pdf) Appeal Number: 21-2275 Origin: DCT Precedential To see more opinions and orders, follow this link: Opinions and Orders."}
# United States Court of Appeals

For the First Circuit

Nos. 19

- 1787
19

- 1900

MARK ANTHONY REID; ROBERT WILLIAMS, on behalf of himself and others similarly situated; LEO FELIX CHARLES, on behalf of

himself and others similarly situated,

Petitioners, Appellants/Cross

- Appellees
,

v.

CHRISTOPHER J. DONELAN, Sheriff, Franklin County, Massachusetts; LORI STREETER, Superintendent, Franklin County Jail & House of Correction; THOMAS M. HODGSON, Sheriff, Bristol County,
Massachusetts; JO SEPH D. MCDONALD, JR., Sheriff, Plymouth County, Massachusetts; STEVEN W. TOMPKINS, Sheriff, Suffolk County, Massachusetts; ALEJANDRO MAYORKA S, Secretary of the Department of Homeland Security; DENIS C. RIORDAN, Director, Immigration and Customs Enforcemen t Boston Field Office; MERRICK B. GARLAND, Attorney General; JEAN K ING, Acting Director of the Executive Office for Immigration Review; EXECUTIVE OFFICE FOR IMMIGRATION REVIEW; DAVID DUBOIS, Sheriff, Straff ord County, New Hampshire; CHRISTOPHER BRACKETT, S uperintendent, Strafford County House of Corrections; TAE D. JOHNSON , Acting Director,

Immigration and Customs Enforcement,

Respondents, Appellees/Cross

- Appellants

.

ERRATA SHEET

The opinion of this Court issued on October 26 , 20 21 is

amended as follows:

On page 5, line 22
, "shall" is replaced with "should"
Exhibit 10.2

Second Amendment to Marketing Agreement

This Second Amendment to Marketing Agreement ("Amendment") dated
September __, 2000, is made and entered into by and between Charles Schwab
& Co., Inc., a California corporation, ("Schwab") and E-LOAN, Inc., a
Delaware corporation ("E-LOAN"), and is effective as of April 25, 2000.

WHEREAS, Schwab and E-LOAN have entered into a Marketing Agreement (the
"Agreement") dated April 25, 2000;

WHEREAS, Schwab and E-LOAN have a mutual desire to amend the Agreement as set
forth in this Amendment.

NOW, THEREFORE, the parties hereby agree as follows:

1.	The Effective Date is hereby amended to reflect a date of July 1,
2000

2.	Section 8.1 of the Agreement is hereby amended to reflect the
Marketing Fee will be due and payable in equal monthly installments commencing
on the Effective Date of the Agreement and ending 48 months from such date.

3.	Except for the changes set forth in this Amendment, the Agreement shall
remain unchanged in all respects, and shall remain in full force and effect in
accordance with its terms.

|E-LOAN, INC.            | CHARLES SCHWAB & CO., INC.
|----------------------- | --------------------------
|By: __________________  | By: __________________    
|Name: _______________   | Name: _______________     
|Title: ________________ | Title: ________________   

---
EXHIBIT 21

                          LIST OF LUMENIS SUBSIDIARIES

I.       Americas

         a.       Lumenis Holdings Inc.                 -- Delaware

         b.       Lumenis Inc.                          -- Massachussetts

         c.       Sharplan Lasers Inc.                  -- Delaware

         d.       FISMA Corporation                     -- Utah

         e.       Instruments for Surgery               -- Wyoming

         f.       Instruments for Medicine
                  and Diagnostics, Inc.                 -- Oregon

         g.       Lumenis (Mexico) SA de CV             -- Mexico

         h.       Applied Optronics Corp.               -- Delaware

         i.       Sahar Technologies Inc.               -- California

         j.       Luxar Corporation                     -- Washington

         k.       Luxar Sales Corporation               -- Washington

II.      Israel

         a.       Laser Industries Ltd.

         b.       Opusdent Ltd.

         c.       Medic Lightech Ltd.

         d.       L.B.T. Ltd.

III. Europe

         a.       Lumenis Holdings (Holland) BV         -- Holland

         b.       Lumenis (Holland) BV                  -- Holland

         c.       Lumenis (UK) Limited                  -- UK

         d.       Sharplan Lasers (UK) Ltd.             -- UK

         e.       Spectron (UK) Ltd.                    -- UK

         f.       Spectron Scientific Lasers (UK)       -- UK

         g.       Spectron Laser GmbH (Germany)         -- Germany

         h.       Spectron Systems Laser Ltd (UK)       -- UK

         i.       Sharplan Lasers (Europe) Ltd.         -- UK

         j.       Lumenis (Germany) GmbH                -- Germany

         k.       Lumenis (Austria) GmbH                -- Austria

         l.       Lumenis (France) Sarl                 -- France

         m.       Lumenis (Italy) Srl                   -- Italy

         n.       Lumenis (Sweden) AB                   -- Sweden

         o.       Lumenis (Luxembourg) Sarl             -- Luxembourg

         p.       Lumenis (Luxembourg) Sarl,
                  Branch Schaffhausen                   -- Swiss Branch


                                     - 1 -

<PAGE>


         q.       Opusdent Germany                      -- Germany

         r.       Opusdent UK (with a French branch)

IV. Asia Pacific

         a.       Lumenis (HK) Ltd.                     -- Hong Kong

         b.       Lumenis Japan Co. Ltd.                -- Japan

         c.       Lumenis Star Co. Ltd.                 -- Japan

         d.       Lumenis (Holland) BV
                  Beijing Office                        -- Dutch subsidiary has
                                                           representative
                                                           offices in China

         e.       Wuhan Sharplan Chutian
                  Medical Laser Manufacturing Ltd.      -- China

         f.       Bejing Service Center

         g.       Aestilight Japan Ltd


                                      - 2 -
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the balance
sheet and statements of operations of the Company as of and for the years ended
December 31, 1999 and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<CIK> 0001004673
<NAME> NAME OF COMPANY
<MULTIPLIER> 1
<CURRENCY> US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                         1169924
<SECURITIES>                                         0
<RECEIVABLES>                                   150074
<ALLOWANCES>                                     20000
<INVENTORY>                                    1642195
<CURRENT-ASSETS>                               3445908
<PP&E>                                         3384434
<DEPRECIATION>                                  532797
<TOTAL-ASSETS>                                 7628925
<CURRENT-LIABILITIES>                          2845964
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         10746
<OTHER-SE>                                      601543
<TOTAL-LIABILITY-AND-EQUITY>                   7628925
<SALES>                                         718896
<TOTAL-REVENUES>                                767729
<CGS>                                          2973459
<TOTAL-COSTS>                                  2973459
<OTHER-EXPENSES>                               5159880
<LOSS-PROVISION>                                 75417
<INTEREST-EXPENSE>                              767850
<INCOME-PRETAX>                              (8133370)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (8133370)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (8133370)
<EPS-BASIC>                                     (0.98)
<EPS-DILUTED>                                   (0.98)


</TABLE>